Skip to main content
. 2022 Nov 1;27:101579. doi: 10.1016/j.tranon.2022.101579

Fig. 1.

Fig 1

Potential clinical applications of miRNAs and lncRNAs. The analysis of diverse types of samples (e.g., PC tissues, serum, plasma, urine, saliva, and stool) can lead to the identification of dysregulated circulating miRNAs and lncRNAs involved in PC progression, which might set the foundations for creating ncRNA-based drugs and diagnostic protocols for PC.